Trials / Unknown
UnknownNCT02762136
Traditional Chinese Medicine Xiang-sha-liu-jun Granules in Patients With Postprandial Distress Syndrome(PDS)
Xiang-sha-liu-jun Granules as an Herbal Formula for the Treatment of Postprandial Distress Syndrome(PDS): a Prospective, Double-blinded, Randomized and Placebo-controlled,Three-center Trial
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 216 (estimated)
- Sponsor
- Xiyuan Hospital of China Academy of Chinese Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Functional dyspepsia (FD), which is one of the most common gastrointestinal disorders with high disease burden. Postprandial distress syndrome (PDS) is a common subtype of FD. Although the effectiveness of Chinese herbal formula of Xiang-sha-liu-jun granule (XSLJG) for alleviating PDS symptoms has been assessed in previous studies, more convinced evidence of randomized placebo-controlled study is needed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | |
| DRUG | Xiang-sha-liu-jun granules | The Xiang-sha-liu-jun granules comprises 10 herbs, Astragalus membranaceus (Huangqi) 15g, Codonopsis pilosula (Dangshen) 15 g, fructus aurantii (Zhiqiao) 15g, fructus amomi(Sharen) etc |
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2017-12-01
- Completion
- 2018-04-01
- First posted
- 2016-05-04
- Last updated
- 2016-05-05
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02762136. Inclusion in this directory is not an endorsement.